Status:

COMPLETED

Impairment of Reading Ability in Dry Eye Patients

Lead Sponsor:

Johns Hopkins University

Collaborating Sponsors:

Allergan

Conditions:

Dry Eye Syndromes

Eligibility:

All Genders

50+ years

Brief Summary

To assess the reading function impairment in patients with dry eye and to assess the effects of reading on the ocular surface.

Detailed Description

This study is being done to understand how reading is affected in people with dry eye in comparison with healthy controls and what effect reading has on the ocular surface in patients with dry eye.

Eligibility Criteria

Inclusion

  • age of 50 or greater,
  • literacy in English language,
  • ability to give informed consent

Exclusion

  • binocular vision below 20/25,
  • any ocular surgery within the last 3 months,
  • mental issues,
  • illiteracy,
  • language problems which might possibly interfere with reading ability,
  • history of taking or current use of topical prescription anti-inflammatory eye drops (including, cyclosporine and steroids as well as any glaucoma eye drops).

Key Trial Info

Start Date :

April 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 1 2015

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT01826812

Start Date

April 1 2013

End Date

November 1 2015

Last Update

February 15 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Wilmer Eye Institute, Johns Hopkins University

Baltimore, Maryland, United States, 21287